stock-detail (OMED)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

Hepatitis C Deaths Hit All-Time High in United States

5/5/2016 11:04 am

(CNN) May 4, 2016 - Hepatitis C-related deaths reached an all-time high in 2014, the Centers for Disease Control and Prevention announced Wednesday, surpassing total combined deaths from 60 other infectious diseases including HIV, pneumococcal disease and tuberculosis.

European Medicines Agency Validates Bristol-Myers Squibb’s Application for Opdivo® (nivolumab) for the Treatment of Classical Hodgkin Lymphoma Patients

3/31/2016 07:00 am

(BMS) Mar 30, 2016 - Bristol-Myers Squibb Company announced today that the European Medicines Agency (EMA) validated a type II variation application, which seeks to extend the current indications for Opdivo to include the treatment of patients with classical Hodgkin lymphoma (cHL) after prior therapies.

Medicare Proposes New Coverage Policy for Stem Cell Transplant for Sickle Cell, Myelofibrosis, and Myeloma

11/17/2015 12:03 pm

(ASH) Nov 12, 2015 - On October 29, 2015, the Centers for Medicare and Medicaid Services (CMS) released a new proposed coverage policy for hematopoietic stem cell transplant for Medicare patients.

Ready for Profound Reimbursement Changes? Read the New ASCO in Action Brief on MACRA

11/17/2015 12:03 pm

(ASCO in Action) Nov 16, 2015 - The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) introduced significant changes, on an ambitious timeline, to how Medicare will pay oncologists for the care they provide—and now is the time to understand and prepare for these changes.

AstraZeneca's Tagrisso To Cost $12,750 For A Month's Supply

11/17/2015 12:02 pm

(Reuters) Nov 17, 2015 - AstraZeneca's new lung cancer pill Tagrisso, which won early U.S. approval on Friday, will cost $12,750 for a month's supply.

Tagrisso™ (osimertinib) Approved for Advanced Lung Cancer, Available Immediately at Biologics, Inc.

11/17/2015 12:02 pm

(Yahoo! Finance) Nov 17, 2015 - Biologics, Inc., is pleased to announce that it has been selected by AstraZeneca as a specialty pharmacy provider for Tagrisso (osimertinib). Tagrisso was designated as a Breakthrough Therapy by the U.S. Food and Drug Administration, and was approved on November 13, 2015, for the treatment of advanced lung cancer.

Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy

11/17/2015 12:01 pm

(Georgia Tech) Nov 17, 2015 - Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.

Deeper Grasp of Chemotherapy-Induced Peripheral Neuropathy

11/17/2015 12:01 pm

(Medscape Medical News) Nov 12, 2015 - Two unrelated studies, both published in the Journal of Clinical Oncology, provide deeper insights into peripheral neuropathy — a disabling side effect experienced by patients on many chemotherapy regimens, particularly regimens containing oxaliplatin (Eloxatin, sanofi-aventis) and paclitaxel (multiple brands).

Nondrug Interventions Improve Quality Of Life For Chinese Cancer Patients

11/17/2015 12:01 pm

(University Of Illinois At Urbana-Champaign) Nov 17, 2015 - A meta-analysis of dozens of studies of traditional Chinese medicine and other nonpharmacological interventions meant to improve patients' quality of life affirms that these approaches, on the whole, help alleviate depression, fatigue, pain, anxiety, insomnia and gastrointestinal problems in Chinese cancer patients.

New Studies Investigating the Use of KEYTRUDA® (pembrolizumab) Across Solid and Hematological Cancers to Be Presented at Upcoming Congresses

11/17/2015 12:01 pm

(Merck) Nov 17, 2015 - Merck, known as MSD outside the United States and Canada, today announced that data investigating the use of KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, in advanced non-small cell lung cancer, melanoma, classical Hodgkin lymphoma, multiple myeloma, and ER-positive/HER2-negative breast cancer will be presented at four medical congresses through the end of this year.

Amgen to Present IMLYGIC (Talimogene Laherparepvec) Data at the 2015 International Congress of the Society for Melanoma Research

11/17/2015 12:01 pm

(Amgen) Nov 16, 2015 - Highlights include analyses from pivotal study and new data from phase 1b combination trial in metastatic melanoma.

Novocure Announces 18 Presentations on Tumor Treating Fields at SNO 2015 Including New Analyses of the EF-14 Newly Diagnosed Glioblastoma Clinical Trial Data

11/17/2015 12:01 pm

(TheStreet) Nov 17, 2015 - Quality of life was maintained throughout treatment with Tumor Treating Fields; EF-14 patients who continued Tumor Treating Fields concurrent with second-line chemotherapy at first recurrence of glioblastoma lived significantly longer than patients who received chemotherapy alone.

Cerulean Announces Clinical Collaboration with AstraZeneca and the National Cancer Institute to Evaluate the Combination of LYNPARZA™ and CRLX101

11/17/2015 12:01 pm

(Yahoo! Finance) Nov 17, 2015 - Three-party collaboration will explore synergies between AstraZeneca’s leading PARP inhibitor and Cerulean’s topoisomerase inhibitor.

Executive View - FDA Approval Is Single Biggest Genmab Moment - CEO

11/17/2015 12:01 pm

(Reuters) Nov 17, 2015 - Danish biotech firm Genmab GEN.CO said late on Monday the U.S. Food and Drug Administration had approved its cancer treatment Darzalex (daratumumab) for blood cancer multiple myeloma.

UK Researchers Develop Pancreatic Cancer Treatment ‘Breakthrough’

11/17/2015 12:00 pm

(PharmaTimes [UK]) Nov 17, 2015 - Ulster University has developed a pioneering treatment for pancreatic cancer, which researchers are hailing as the first breakthrough in over 40 years that could significantly boost survival rates.

Nanotech-based Sensor Developed To Measure MicroRNAS In Blood, Speed Cancer Detection

11/17/2015 12:00 pm

(Indiana University-Purdue University Indianapolis) Nov 17, 2015 - A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.

Pre-Op Blood Tests May Predict Post-Op Morbidity in Ovarian CA

11/17/2015 12:00 pm

(Physician’s Briefing/HealthDay News) Nov 16, 2015 - Pre-op thrombocytosis, leukocytosis tied to post-op morbidity; increased mortality for patients with both.

Indoor Tanning Rates Dropping

7/8/2015 11:04 am

(Fox News/Reuters) July 8, 2015 - Use of indoor tanning is on the decline, according to a new study from the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute.

Opdivo (nivolumab) Demonstrates Superior Survival Compared to Standard of Care (docetaxel) for Previously-Treated Squamous Non-Small Cell Lung Cancer in Phase III Trial

5/31/2015 06:05 pm

(BMS) May 31, 2015 - Bristol-Myers Squibb Company today announced results from CheckMate -017, a Phase III, open-label, randomized study evaluating Opdivo (n=135) versus docetaxel (n=137) in previously treated patients with advanced squamous non-small cell lung cancer.

Penn Medicine Study Reveals Why Almost Half of At-Risk Patients Opt Out of Comprehensive Multiplex Cancer Screening

5/7/2015 12:00 pm

(Penn Medicine) May 7, 2015 - Some at-risk patients opted out of comprehensive cancer gene screening when presented with the opportunity to be tested for the presence of genes linked to various cancers, according to a recent study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Basser Center for BRCA in Penn’s Abramson Cancer Center.

Walking Improves Mood, Boosts Energy in Cancer Survivors

4/24/2015 11:01 am

(Medscape Medical News) Apr 23, 2015 - Two studies, one from Europe and one from the United States, advise cancer survivors to be physically active to reduce adverse effects from chemotherapy and improve their health-related quality of life (HRQOL).

Researchers Find Protein That May Signal More Aggressive Prostate Cancers

4/13/2015 11:04 am

(University of Michigan) Apr 13, 2015 - University of Michigan researchers have discovered a biomarker that may be a potentially important breakthrough in diagnosing and treating prostate cancer.

Study Backs HPV Vaccine for Boys

4/13/2015 07:00 am

(Toronto Star) Apr 13, 2015 - Vaccinating boys against the human papillomavirus could help reduce throat cancers and save millions, says study in journal Cancer.

Many Head and Neck Cancer Survivors Don't Return to Work

4/10/2015 12:02 pm

(Physician's Briefing/HealthDay News) Apr 9, 2015 - Many head and neck cancer survivors do not return to work, according to a study published in the April issue of Head & Neck.

Most Women With Early-Stage Breast Cancer Avoid Extensive Lymph Node Removal, Showing Increasing Adherence to Scientific Evidence That a Radical Operation Is No Longer Necessary

3/27/2015 11:01 am

(American College of Surgeons) Mar 26, 2015 - A new study of women with early-stage breast cancer finds that surgeons no longer universally remove most of the lymph nodes in the underarm area when a biopsy of the nearby lymph nodes shows cancer--a major change in breast cancer management.